Outcome measures and covariates | Time points (months) | ||||
---|---|---|---|---|---|
 | ~ -3 | 0 | 6 | 12 | 18 |
MMSE | x | x | Â | Â | x |
Cognitive measures | Â | x | x | x | x |
Physical activity, functional capacity, and well-being measures | Â | x | x | x | x |
Height | Â | x | Â | Â | Â |
Blood pressure, weight | Â | x | x | x | x |
Erythrocyte membrane n-3 and n-6 fatty acid status | Â | x | x | x | x |
Serum folate and Vitamin B12, and plasma carotenoid levels | Â | x | Â | Â | x |
Lipids, glucose, glycated haemoglobin, homocysteine | Â | x | Â | Â | x |
Medications, supplement use, adverse events and health changes | Â | x | x | x | x |
ApoE genotype | Â | x | Â | Â | Â |
Inflammation (CRP), oxidative stress (MDA), and telomere length | Â | x | Â | Â | x |
Dietary data - general FFQ | Â | x | Â | Â | x |
Dietary data - n-3 consumption FFQ | Â | x | x | x | x |
Dietary data - historical seafood consumption FFQ | Â | Â | x | Â | Â |